ciprofloxacin has been researched along with deferiprone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
Chang, YQ; Chen, WM; Hou, JS; Lin, J; Liu, J; Miao, ZY; Peng, LJ; Sun, PH; Zhang, XY | 1 |
Coenye, T; Prestidge, CA; Richter, K; Thomas, N; Vreugde, S; Wormald, PJ; Zhang, G | 1 |
3 other study(ies) available for ciprofloxacin and deferiprone
Article | Year |
---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
New
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Pyridines; Quinolones; Quorum Sensing; Zebrafish | 2022 |
Deferiprone and Gallium-Protoporphyrin Have the Capacity to Potentiate the Activity of Antibiotics in
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Biofilms; Caenorhabditis elegans; Ciprofloxacin; Colony Count, Microbial; Deferiprone; Disease Models, Animal; Drug Combinations; Drug Synergism; Gallium; Gentamicins; Hydrogels; Iron; Microbial Sensitivity Tests; Protoporphyrins; Pyridones; Staphylococcal Infections; Staphylococcus aureus; Survival | 2017 |